"gold report (2025): copd strategy" MCQ (SBA): In severe COPD with chronic bronchitis and frequent exacerbatio
Instant feedback + full explanation. One question, done properly.
Hard"A"In severe COPD with chronic bronchitis and frequent exacerbations despite optimal inhaled therapy, roflumilast can reduce exacerbations. LABA alone or stopping ICS is inappropriate; theophylline/steroids are not recommended chronically due to limited benefit and toxicity."gold report (2025): copd strategy"
Educational content. Not a substitute for clinical judgement or local policy.